- $2.05bn
- $2.72bn
- $1.34bn
- 76
- 84
- 61
- 86
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,218 | 1,300 | 1,721 | 1,433 | 1,336 |
Cost of Revenue | |||||
Gross Profit | 862 | 867 | 837 | 885 | 896 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 849 | 926 | 1,464 | 1,173 | 1,094 |
Operating Profit | 369 | 374 | 257 | 260 | 242 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 368 | 384 | 251 | 327 | 250 |
Provision for Income Taxes | |||||
Net Income After Taxes | 545 | 291 | 305 | 268 | 175 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 109 | 130 | 288 | 266 | 175 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.94 | 599 | 261 | 266 | 175 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.03 | 4.81 | 2.32 | 2.39 | 1.97 |
Dividends per Share |